Concerning glycoproteins, exosomes derived from ovarian cancer patients carry the putative cancer marker glycosylated molecules CD24 and EpCAM, supporting their potential in diagnostics [42,43]. This evidence concerns the gene CD24 and ovarian carcinoma.